Company intelligence / Profile preview
Bio Balance, Inc.
- Ownership
- Private
- Employees
- ~3
- Development stage
- Commercial
Overview
Bio Balance focuses on bridging basic research and practical applications in drug discovery through detailed study of molecular interactions between drugs and receptors. The company aims to improve pharmaceutical development using advanced biophysical methods but does not report clinical results or marketed products at this time.
- Therapeutic areas
- Other
- Modalities
- Focus on drug-receptor interactions and biophysical approaches to pharmaceutical development; specific modalities such as small molecules or biologics are not explicitly listed but likely include small molecule therapeutics based on their research focus
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Bio Balance, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio Balance, Inc..